Unmasking Postpartum Depression: Elevating Awareness, Understanding Impact, and Recognising Unmet Needs

This video has been created and funded by Biogen. For Healthcare Professionals only

Disclosures: Quiroga is on the speakers’ bureau, and/or consultant for Biogen, Idorsia, Casen-Recordati, Johnson & Johnson, Novartis, Takeda, Bial, Shire, Neuraxpharm, Novartis, BMS, Medice, Rubió, Uriach, TechnoFarma, and Raffo in the last 3 years; has received travel awards (air tickets + accommodation) for taking part in psychiatric meetings from Idorsia, Johnson & Johnson, Rubió, Takeda, Bial, and Medice; and The Department of Psychiatry chaired by Quiroga received unrestricted educational and research support from the following companies in the last 3 years: Exeltis, Idorsia, Johnson & Johnson, Neuraxpharm, Oryzon, Roche, Probitas, and Rubió.  

Gomes has been a Speaker for Biogen, Abbott, Apsen, Daiichi-Sankyo, Eurofarma, GnTech, Janssen, Lundbeck, Torrent; provided Scientific Support to Apsen, Janssen, Lundbeck and sits on the Advisory Board for Biogen. 

Cantilino has been a speaker for Biogen, Daiichi-Sankyo, EMS, Janssen, Libbs and is on the advisory board of Biogen and Viatris. 

In this educational symposium from the 33^rd European Congress of Psychiatry (EPA) 2025, Ramos Quiroga, Igor Emanuel, and Amaury Cantilino provide a holistic overview of postpartum depression (PPD), its negative consequences, and recognition and management. 

Topics covered:

• What is PPD, and how common is it?  
• How can PPD develop?  
• What are the consequences of PPD?  
• What can we do to detect and manage PPD? 

1. University Hospital Vall d’Hebron, Autonomous University of Barcelona, Spain
2. I Psi Clinic Fortaleza, Brazil
3. Clinical Hospital of the Federal University of Pernambuco, Recife, Brazil

Biogen-276726 | November 2025